Immunolymphoscintigraphy for Identifying Metastatic Sentinel Nodes
Author Information
Author(s): A. H. Chakera, B. S. Nielsen, J. Madsen, J. Romer, P. E. G. Kristjansen, I. Buch, T. Binderup, C. Ingvar, A. Nalla, A. Kjaer, B. Hesse
Primary Institution: Rigshospitalet, Copenhagen, Denmark
Hypothesis
Can immunolymphoscintigraphy effectively identify metastatic sentinel nodes using radiolabelled antibodies?
Conclusion
The study suggests that immunolymphoscintigraphy could be a viable method for noninvasive imaging of malignant sentinel nodes.
Supporting Evidence
- Immunohistoautoradiography showed specific binding of the anti-MUC1 antibody to breast cancer cells.
- Gamma camera imaging demonstrated retention of the radiolabelled antibody in xenograft tumors.
- Subcutaneous injection in rabbits showed drainage of radiolabelled IgG through lymphatic vessels.
Takeaway
This study is about using special antibodies to find cancer in lymph nodes without surgery, which could help doctors plan better treatments.
Methodology
The study involved testing radiolabelled antibodies in mice and rabbits to visualize their binding to cancer cells and their transport to lymph nodes.
Potential Biases
There is a small risk of developing human antimouse antibodies with repeated injections of murine monoclonal antibodies.
Limitations
The study was limited by the small number of animals used and the inability to test in a larger animal model with malignant tumors.
Participant Demographics
The study involved immune-deficient nude mice and healthy rabbits.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website